Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Pharmacometric Methods: Essential for Optimal Drug Development Strategy
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 367
Date: Wednesday, June 26, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 203
CHAIR :
 Royce A. Morrison, MD,MS (SCHNON), Executive Vice-Chair, Quorum Review, Inc., United States
SPEAKER (S):
Amit Roy, (SPKNON), Group Director, Clinical Pharmacology and Pharmacometrics R&D, Bristol-Myers Squibb Company, United States
Haiyan Jiang, PhD (SPKNON), Senior Director, Preclinical and Clinical Research (Hemophilia), Biogen Idec, United States
David S Small, PhD (SPKNON), Research Advisor, Global Pharmacokinetics/Pharmacodynamics, Eli Lilly and Company, United States
Description
This session will explore the definition of pharmacometrics, its key role in strategy, program planning, study design, labeling and regulatory decision-making, and its rapidly developed implementation by regulatory agencies.

Session Recording
(Code: 367)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 367)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Pharmacometric Methods: Essential for Optimal Drug Development Strategy